Qinglei Gao

2 clinical trials · Sponsor

Record	Firm	Date
A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neoadjuvant Therapy in Patients With Advanced Ovarian Cancer (NCT07355010)	Qinglei Gao	2025-12-30

Every clearance here is in the API, with alerts when new ones post.